Nives Zimmermann

Dr. Nives Zimmermann

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GKGen Kano
Gen Kano
MAMaha Almanan
Maha Almanan
BBBruce S. Bochner
Bruce S. Bochner
NZNives Zimmermann
Nives Zimmermann

23 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TSTetsuo Shoda
Tetsuo Shoda
KKKenneth M. Kaufman
Kenneth M. Kaufman
TWTing Wen
Ting Wen
JCJulie M. Caldwell
Julie M. Caldwell
GOGarrett A. Osswald
Garrett A. Osswald
MRMarc E. Rothenberg
Marc E. Rothenberg
Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease with a complex underlying genetic etiology. Herein, we conduct whole-exome sequencing of a multigeneration EoE pedigree (discovery set) and 61 additional multiplex families with EoE (replication set). A series of rare, heterozygous, missense variants are identified in the genes encoding the desmosome-associated proteins DSP and PPL in 21% of the multiplex families. Esophageal biopsies from patients with these variants retain dilated intercellular spaces and decrease DSP and PPL expression even during disease remission. These variants affect barrier integrity, cell motility and RhoGTPase activity in esophageal epithelial cells and have increased susceptibility to calpain-14–mediated degradation. An acquired loss of esophageal DSP and PPL is present in non-familial EoE. Taken together, herein, we uncover a pathogenic role for desmosomal dysfunction in EoE, providing a deeper mechanistic understanding of tissue-specific allergic responses.

3 October 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MRMarc E. Rothenberg
Marc E. Rothenberg
MDMatthew P. Doepker
Matthew P. Doepker
ILIan P. Lewkowich
Ian P. Lewkowich
MCMonica G. Chiaramonte
Monica G. Chiaramonte
KSKeith F. Stringer
Keith F. Stringer
NZNives Zimmermann
Nives Zimmermann
Arginine is an amino acid that serves as a substrate for nitric oxide synthase and arginase. As such, arginine has the potential to influence diverse fundamental processes in the lung. Here we report that the arginine transport protein, cationic amino acid transporter (CAT)2, has a critical role in regulating lung inflammatory responses. Analysis of CAT2-deficient mice revealed spontaneous inflammation in the lung. Marked eosinophilia, associated with up-regulation of eotaxin-1, was present in the bronchoalveolar lavage fluid of 3-week-old CAT2-deficient mice. The eosinophilia was gradually replaced by neutrophilia in adult mice, while eotaxin-1 levels decreased and GRO-α levels increased. Despite the presence of activated alveolar macrophages in CAT2-deficient mice, NO production was compromised in these cells. Examination of dendritic cell activation, which can be affected by NO release, indicated increased dendritic cell activation in the lungs of CAT2-deficient mice. This process was accompanied by an increase in the number of memory T cells. Thus, our data suggest that CAT2 regulates anti-inflammatory processes in the lungs via regulation of dendritic cell activation and subsequent T cell responses.

24 May 2013 in BMC Immunology
Verified
Journal Article
Open access
PDF file
XZXiang Zhu
Xiang Zhu
EMEucabeth Mose
Eucabeth Mose
NZNives Zimmermann
Nives Zimmermann
Background: Proton currents are required for optimal respiratory burst in phagocytes. Recently, HVCN1 was identified as the molecule required for the voltage-gated proton channel activity associated with the respiratory burst in neutrophils. Although there are similarities between eosinophils and neutrophils regarding their mechanism for respiratory burst, the role of proton channels in eosinophil functions has not been fully understood.Results: In the present study, we first identified the expression of the proton channel HVCN1 in mouse eosinophils. Furthermore, using HVCN1-deficient eosinophils, we demonstrated important cell-specific effector functions for HVCN1. Similar to HVCN1-deficient neutrophils, HVCN1-deficient eosinophils produced significantly less reactive oxygen species (ROS) upon phorbol myristate acetate (PMA) stimulation compared with WT eosinophils. In contrast to HVCN1-deficient neutrophils, HVCN1-deficient eosinophils did not show impaired calcium mobilization or migration ability compared with wild-type (WT) cells. Uniquely, HVCN1-deficient eosinophils underwent significantly increased cell death induced by PMA stimulation compared with WT eosinophils. The increased cell death was dependent on NADPH oxidase activation, and correlated with the failure of HVCN1-deficient cells to maintain membrane polarization and intracellular pH in the physiological range upon activation.Conclusions: Eosinophils require proton channel HVCN1 for optimal ROS generation and prevention of activation-induced cell death.

24 June 2010 in Respiratory Research
Verified
Journal Article
Open access
PDF file
KNKathryn A Niese
Kathryn A Niese
MCMonica G Chiaramonte
Monica G Chiaramonte
LELesley G. Ellies
Lesley G. Ellies
MRMarc E Rothenberg
Marc E Rothenberg
NZNives Zimmermann
Nives Zimmermann
Arginine is an amino acid that serves as a substrate for the enzymes nitric oxide synthase (NOS) and arginase, leading to synthesis of NO and ornithine, respectively. As such, arginine has the potential to influence diverse fundamental processes in the lung.

1 June 2009 in BMC Immunology
Verified
Journal Article
Open access
PDF file
KNKathryn A Niese
Kathryn A Niese
ACAnn R Collier
Ann R Collier
AHAmanda R Hajek
Amanda R Hajek
SCStephen D Cederbaum
Stephen D Cederbaum
WOWilliam E O'BRien
William E O'BRien
NZNives Zimmermann
Nives Zimmermann
Background: Arginase is significantly upregulated in the lungs in murine models of asthma, as well as in human asthma, but its role in allergic airway inflammation has not been fully elucidated in mice.Results: In order to test the hypothesis that arginase has a role in allergic airway inflammation we generated arginase I-deficient bone marrow (BM) chimeric mice. Following transfer of arginase I-deficient BM into irradiated recipient mice, arginase I expression was not required for hematopoietic reconstitution and baseline immunity. Arginase I deficiency in bone marrow-derived cells decreased allergen-induced lung arginase by 85.8 ± 5.6%. In contrast, arginase II-deficient mice had increased lung arginase activity following allergen challenge to a similar level to wild type mice. BM-derived arginase I was not required for allergen-elicited sensitization, recruitment of inflammatory cells in the lung, and proliferation of cells. Furthermore, allergen-induced airway hyperresponsiveness and collagen deposition were similar in arginase-deficient and wild type mice. Additionally, arginase II-deficient mice respond similarly to their control wild type mice with allergen-induced inflammation, airway hyperresponsiveness, proliferation and collagen deposition.Conclusion: Bone marrow cell derived arginase I is the predominant source of allergen-induced lung arginase but is not required for allergen-induced inflammation, airway hyperresponsiveness or collagen deposition.